Akso Health Group Research and Development Expense
Akso Health Group (AHG) reported Research and Development Expense of $64.77 thousand for the 6-month period ending 2022-09-30, per its 6-K filed 2023-02-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2023-02-16
| Period end | Research and Development Expense 6 month | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|
| 2022-09-30 | $64.77K 6-K · filed 2023-02-16 | ||
| 2022-03-31 | $421.19K 20-F · filed 2022-12-29 | ||
| 2021-09-30 | $225.29K 6-K · filed 2023-02-16 | ||
| 2021-03-31 | $441.40K 20-F · filed 2022-12-29 | ||
| 2020-03-31 | $117.94K 20-F · filed 2022-12-29 | $3.16M 20-F · filed 2020-08-14 | |
| 2019-03-31 | $0.00 20-F · filed 2021-07-28 | $1.15M 20-F · filed 2019-07-31 | |
| 2018-03-31 | $2.82M 20-F · filed 2020-08-14 | ||
| 2017-03-31 | $1.57M 20-F · filed 2019-07-31 | ||
| 2016-03-31 | $895.99K 20-F · filed 2018-07-30 |